MENU
+Compare
MIRA
Stock ticker: NASDAQ
AS OF
Apr 3, 04:54 PM (EDT)
Price
$0.89
Change
-$0.06 (-6.32%)
Capitalization
16.26M

MIRA MIRA Pharmaceuticals Forecast, Technical & Fundamental Analysis

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders... Show more

MIRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for MIRA with price predictions
Apr 02, 2025

MIRA in +6.67% Uptrend, rising for three consecutive days on March 21, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where MIRA advanced for three days, in of 46 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The 10-day moving average for MIRA crossed bullishly above the 50-day moving average on March 21, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 5 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

MIRA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The 10-day RSI Indicator for MIRA moved out of overbought territory on March 14, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 7 similar instances where the indicator moved out of overbought territory. In of the 7 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on March 27, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on MIRA as a result. In of 25 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for MIRA turned negative on March 28, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 13 similar instances when the indicator turned negative. In of the 13 cases the stock turned lower in the days that followed. This puts the odds of success at .

MIRA moved below its 50-day moving average on March 27, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MIRA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for MIRA entered a downward trend on March 12, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.931) is normal, around the industry mean (5.632). P/E Ratio (0.000) is within average values for comparable stocks, (48.974). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.004). Dividend Yield (0.000) settles around the average of (0.161) among similar stocks. MIRA's P/S Ratio (0.000) is slightly lower than the industry average of (3.643).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. MIRA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MIRA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock worse than average.

View a ticker or compare two or three
MIRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

MIRA is expected to report earnings to fall 31.91% to -15 cents per share on May 28

MIRA Pharmaceuticals MIRA Stock Earnings Reports
Q1'25
Est.
$-0.16
Q4'24
Missed
by $0.11
Q3'24
Missed
by $0.03
Q2'24
Beat
by $0.01
Q1'24
Beat
by $0.04
The last earnings report on February 26 showed earnings per share of -23 cents, missing the estimate of -12 cents. With 86.50K shares outstanding, the current market capitalization sits at 16.26M.
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
N/A
Address
855 N Wolfe Street
Phone
+1 737 289-0835
Employees
7
Web
https://www.mirapharmaceuticals.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SFBS82.211.28
+1.58%
ServisFirst Bancshares
NTAP90.491.00
+1.12%
NetApp
PDLB12.840.13
+1.02%
Ponce Financial Group
EDTK1.01N/A
-0.48%
Skillful Craftsman Education Technology Limited
TCPC7.96-0.09
-1.12%
BlackRock TCP Capital Corp

MIRA and Stocks

Correlation & Price change

A.I.dvisor tells us that MIRA and OGN have been poorly correlated (+11% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MIRA and OGN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MIRA
1D Price
Change %
MIRA100%
-0.73%
OGN - MIRA
11%
Poorly correlated
+4.18%
RHHBF - MIRA
8%
Poorly correlated
-6.61%
RHHVF - MIRA
8%
Poorly correlated
-0.18%
SNYNF - MIRA
7%
Poorly correlated
N/A
ABBV - MIRA
6%
Poorly correlated
-0.52%
More

Groups containing MIRA

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MIRA
1D Price
Change %
MIRA100%
-0.73%
Pharmaceuticals
category (304 stocks)
11%
Poorly correlated
-0.84%
Pharmaceuticals: Major
category (58 stocks)
8%
Poorly correlated
-0.17%